← Leaderboards
Es S Nuwayser
Biotek, Inc.
$1,139,242
Attributed
$1,139,242
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,139,242 · 3
By mechanism
R44$572,822 · 1
N44$566,420 · 2
Top collaborators
No co-investigators on record.
Most similar at Biotek, Inc.
Same institution · by research overlap
- Larry D Nichols$4,539,971
- Elie Nuwayser$643,703
- J P Kitchell$196,540
Others in their field
Top investigators on “Drug Screening /Evaluation”
- Fred M Gordin · Social And Scientific Systems, Inc.$68,001,399
- John C S Breitner · Johns Hopkins University$33,065,187
- Philip J Disaia · University Of California Irvine$21,551,991
- George R Painter · Chimerix, Inc.$19,230,662
- Gregory H Reaman · National Childhood Cancer Foundation$17,052,970
- Stephen J Durako · Westat, Inc.$15,048,684
Research focus
Drug Screening /EvaluationHuman SubjectDosage FormsPharmacokineticsClinical ResearchDrug Administration Rate /DurationDrug Administration RoutesDrug Adverse EffectDrug Design /Synthesis /ProductionEpilepsyHuman Therapy EvaluationInjection /InfusionLaboratory RabbitLorazepamMicrocapsuleRectum /AnusAcidity /AlkalinitySlow Release DrugBrain Disorder ChemotherapyChemical StabilityClinical Trial Phase IClonazepam